Clinical Trial Update: First-in-Human Single Ascending Dose of SHR0302 [Phase 1]

View source ↗

Summary

Phase 1 first-in-human single ascending dose study of SHR0302 in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: UNKNOWN